<DOC>
	<DOCNO>NCT02220504</DOCNO>
	<brief_summary>This open-label , non-randomized , prospective study evaluate risk symptom recurrence three year antipsychotic discontinuation sample functionally recover first-episode patient schizophrenia spectrum disorder .</brief_summary>
	<brief_title>3-year Follow-up Clinical Outcome After Antipsychotic Treatment Discontinuation Psychosis Individuals</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Schizophrenia Spectrum Other Psychotic Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Individuals include First Episode Psychosis Clinical Program ( PAFIP ) University Hospital Marqu√©s de Valdecilla ( Santander , Spain ) . A minimum 18 month antipsychotic treatment . Meeting clinical remission criterion least 12 month prior inclusion . Meeting functional recovery criterion least 6 month prior inclusion . Stabilized low effective dos least 3 month prior inclusion . Meeting Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) criteria drug dependence . Meeting DSMIV criterion mental retardation . Having history neurological disease head injury .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Treatment</keyword>
	<keyword>Maintenance</keyword>
</DOC>